9YSQ
Structure of a human NUAK1-MARK3 kinase domain chimera in complex with inhibitor
This is a non-PDB format compatible entry.
Entity
| Entity ID | Chain ID | Description | Type | Chain length | Formula weight | Number of molecules | DB Name (Accession) | Biological source | Descriptive keywords |
| 1 | A, B (A, B) | MAP/microtubule affinity-regulating kinase 3 | polymer | 328 | 37872.8 | 2 | UniProt (P27448) | Homo sapiens (human) | C-TAK1,cTAK1,Cdc25C-associated protein kinase 1,ELKL motif kinase 2,EMK-2,Protein kinase STK10,Ser/Thr protein kinase PAR-1,Par-1a,Serine/threonine-protein kinase p78 |
| 2 | C, D (A, B) | 3-({5-chloro-2-[2-(difluoromethoxy)-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl}amino)thiophene-2-carboxamide | non-polymer | 510.0 | 2 | Chemie (A1CZY) | |||
| 3 | E, F (A, B) | water | water | 18.0 | 55 | Chemie (HOH) |
Sequence modifications
A, B: 48 - 370 (UniProt: P27448)
| PDB | External Database | Details |
|---|---|---|
| Gly 43 | - | expression tag |
| Ala 44 | - | expression tag |
| Met 45 | - | expression tag |
| Gly 46 | - | expression tag |
| Ser 47 | - | expression tag |
| Leu 62 | Ile 62 | engineered mutation |
| Arg 72 | Leu 72 | engineered mutation |
| Ile 116 | Val 116 | engineered mutation |
| Lys 137 | Gly 137 | engineered mutation |
| Tyr 141 | Phe 141 | engineered mutation |
| Glu 146 | Ala 146 | engineered mutation |
Sequence viewer
Contents of the asymmetric unit
| Polymers | Number of chains | 2 |
| Total formula weight | 75745.6 | |
| Non-Polymers* | Number of molecules | 2 |
| Total formula weight | 1019.9 | |
| All* | Total formula weight | 76765.5 |






